_256_384.png){kind=logo}
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
The trial will be conducted across 10 sites in India
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
The syrup launched by company's Chezgreen division is designed to provide supportive care in managing common menstrual concerns such as amenorrhea, dysmenorrhea, and menorrhagia
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
Subscribe To Our Newsletter & Stay Updated
